Home
Nitroxyl Technology
Cardioxyl has developed industry leading expertise in nitroxyl (HNO) chemistry and biology, and is employing its nitroxyl chemistry platform to discover and develop novel, proprietary therapeutics targeting cardiovascular disease.
Read More
CXL-1020
CXL-1020, a proprietary compound generated by Cardioxyl's nitroxyl chemistry platform, has recently completed a Phase IIa clinical trial in acute decompensated heart failure.
Read More
